Back to search

University of Thessaly (UTH)

Study of the effect of repeated anaesthetic drug administrations on the degree of sedation and safety in dogs and cats

Abstract

dc:description

The present study aimed to evaluate the effect of the consecutive administration of sedative or opioid drugs following an initial dexmedetomidine administration, on the degree and duration of sedation, quality of recovery and safety in dogs and cats. Dexmedetomidine is frequently used in the clinical practice as a pre–anaesthetic or sedative agent in dogs and cats. In some cases, during sedation process, the administered 156dose of dexmedetomidine is not sufficient to perform the required procedure, which raises the question of whether an additional dose of dexmedetomidine or another anaesthetic drug can enhance its effect and induce the required sedation, while maintaining a safe anaesthesia. According to the existing literature, there is insufficient data on the action of dexmedetomidine when it is re–administered, in case the first dose did not induce the required sedation. Moreover, there is insufficient data regarding the specific effects of commonly used drugs administered after an initial dose of dexmedetomidine. This study evaluated this sedative effect and the safety of repeated administrations of dexmedetomidine, as well as the combination of dexmedetomidine with other common sedative drugs, such as butorphanol, buprenorphine, tramadol, midazolam and ketamine. In addition, the study examined whether the second dose of dexmedetomidine would induce satisfactory and safe sedation, and which of the individual additional drugs provided the most effective sedation in animals following an insufficient dose of dexmedetomidine. This thesis included two prospective, crossover, blind and randomised studies in dogs and cats. The study in dogs included a total of six healthy, adult Beagles and the study in cats included six healthy, adult common European cats. The animals participated into seven different groups according to the sedative combination used. All animals received an initial dose of dexmedetomidine IM. The initial administration of dexmedetomidine was followed by an IM administration of a second dexmedetomidine dose or by the administration of butorphanol, buprenorphine, tramadol, midazolam, ketamine or saline. The degree of sedation was assessed using the Grint sedation scale, while the quality of recovery was assessed using the simple descriptive scale of Lozano et al. and the quality of recovery scale of Sams et al. To assess the safety of the administered drugs, repeated measurements of heart and respiratory rates, glucose, cardiac troponin I (cTnI) and creatinine, as well as repeated arterial or venous blood gas analyses were performed. A quantitative regression model and multilevel parametric survival models, as well as the Wilcoxon test and paired t–tests were used for data analysis. In the cats of the study, the repeated administration of dexmedetomidine and the combination of dexmedetomidine with butorphanol or with ketamine enhanced the level and duration of sedation. Administration of midazolam negatively affected the initial dexmedetomidine sedation and prolonged recovery. The drug combinations administered did not affect acid-base balance, electrolytes, renal and cardiac function. Respiratory rate and partial pressure of oxygen were significantly reduced by the administration of dexmedetomidine in combination with opioids, but the values remained within normal limits. The administration of the drug combinations significantly increased glucose values and decreased haematocrit and hemoglobin values, although within normal limits. In the dogs of the study, repeated administration of dexmedetomidine did not improve the quality or duration of sedation. On the contrary, the sedative effect of dexmedetomidine was enhanced by the addition of opioids. Administration of midazolam or ketamine negatively affected the initial sedation and the quality of recovery. A significant decrease in heart and respiratory rates, as well as partial pressure 157of oxygen, was observed, although within normal limits. Cardiac troponin I and creatinine concentrations were not significantly affected. Dexmedetomidine administration significantly increased glucose concentrations. The hyperglycemic effect of dexmedetomidine was attenuated by the administration of opioids and midazolam. The administration of the drug combinations reduced hematocrit and hemoglobin concentrations, while they remained within normal limits. Supplemental oxygen may be beneficial during the administration of sedative protocols including dexmedetomidine. Due to changes in glucose and haematocrit concentrations, the above protocols are not recommended in cats and dogs with hyperglycemia or anaemia.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Margeti, Chrysoyla-Chrysovalanti
  • Μαργέτη, Χρυσούλα-Χρυσοβαλάντη

Subjects

dc:subject × 13

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58526

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Margeti, Chrysoyla-Chrysovalanti; Μαργέτη, Χρυσούλα-Χρυσοβαλάντη. Study of the effect of repeated anaesthetic drug administrations on the degree of sedation and safety in dogs and cats. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/58526